Can varenicline help reduce falls in Parkinson disease?
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This phase 2 trial tests a medicine called varenicline (brand name Chantix) to see if it can reduce falls in people with Parkinson disease who also have a specific brain change (loss of a chemical called acetylcholine in the back of the brain) and mild cognitive problems. The study will help determine if this medicine is safe and effective for this group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Parkinson disease by a movement disorder specialist.
- You have mild cognitive impairment (some memory or thinking problems but not dementia) linked to Parkinson disease.
- You have a specific type of brain scan finding (low acetylcholine activity in the back of the brain) that will be checked by a special PET scan during screening.
- You are not currently using nicotine products (like cigarettes, e-cigarettes, or nicotine patches), anticholinergic drugs (like trihexyphenidyl or benztropine), or certain other medicines (your doctor will review).
- You can swallow pills and are willing to take study medication daily for the trial period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called pimavanserin to see if it helps reduce impulse control problems (like compulsive gambling or eating) in people with Parkinson's disease. If you struggle with these behaviors, this treatment might bring relief.
This trial tests if adding vinpocetine to standard levodopa treatment can help Parkinson's disease patients. It aims to see if this combination improves symptoms.
This trial tests if a low dose of carbon monoxide (HBI-002) is safe and helpful for people with Parkinson's disease. It requires specific health criteria and stable Parkinson's medication.
This trial tests whether varenicline helps people with schizophrenia or schizoaffective disorder stop smoking. It also looks at related nervous-system side effects that can happen with some anti-psychotic medicines.
This study tests whether a medication called varenicline (often used to help people stop smoking) can help reduce cannabis use in people with cannabis use disorder. If you qualify, you'll receive the medication or a placebo and be followed to see how it affects your cannabis use.
This study uses a wearable device to assess fall risk in people with Parkinson's disease who are about to start a new medication. The goal is to see if the device can help predict falls, which may improve safety and treatment planning.
Hear when a new Parkinson Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.